We are live on
!
Find out more
MAM
Mastrapasqua Asset Management Portfolio holdings
AUM
$853M
1-Year Est. Return
37.36%
This Fund
S&P 500
This Quarter
Est. Return
+4.8%
1 Year Est. Return
+37.36%
3 Year Est. Return
+54.87%
5 Year Est. Return
+127.67%
10 Year Est. Return
–
AUM
$435M
AUM Growth
+$9.07M
(+2.1%)
Cap. Flow
-$8.39M
Cap. Flow
% of AUM
-1.93%
Top 10 Holdings %
Top 10 Hldgs %
23.16%
Holding
160
New
9
Increased
75
Reduced
56
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$5.82M |
| 2 |
Verizon
VZ
|
+$5.56M |
| 3 |
Amdocs
DOX
|
+$4.21M |
| 4 |
RTN
Raytheon Company
RTN
|
+$3.71M |
| 5 |
Gilead Sciences
GILD
|
+$2.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$6.27M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$5.57M |
| 3 |
Omnicom Group
OMC
|
+$5.22M |
| 4 |
Northern Trust
NTRS
|
+$4.17M |
| 5 |
Dover
DOV
|
+$4.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.23% |
| 2 | Industrials | 16.21% |
| 3 | Healthcare | 13.97% |
| 4 | Consumer Discretionary | 11% |
| 5 | Materials | 9.63% |
Similar funds
FBA
FDCC
IWP
DBT
CCA
FMAEN1
WWM
RWA
Mastrapasqua Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Mastrapasqua Asset Management held 160 positions worth $435M, up 2.1% from $426M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Mastrapasqua Asset Management's Q2 2014 filing shows 9 new, 75 increased, 56 reduced and 12 closed positions. Its largest new stake was Oracle: 141,555 shares worth $5.74M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $6.27M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.
- Mastrapasqua Asset Management's largest Q2 2014 buy was Oracle: 141,555 shares worth $5.74M.
- Mastrapasqua Asset Management added most to Verizon in Q2 2014, an estimated $5.56M increase.
- Mastrapasqua Asset Management's biggest Q2 2014 reduction was Bristol-Myers Squibb, cutting an estimated $5.57M.
- Mastrapasqua Asset Management fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2014, selling an estimated $6.27M.
- Mastrapasqua Asset Management's ten largest holdings make up 23% of its $435M portfolio in Q2 2014.
- Mastrapasqua Asset Management opened 9 new positions and closed 12 in Q2 2014.
- Mastrapasqua Asset Management's portfolio value rose 2.1% quarter-over-quarter to $435M.
Based on Mastrapasqua Asset Management's 13F filing for Q2 2014, filed 18 Aug 2014.